Study of Anlotinib in Patients With Primary Malignant Bone Tumors
Clinical trial NCT03527888 · UNKNOWN
Trial details
- NCT number
- NCT03527888
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-31
- Primary completion
- 2019-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.